Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

Clinical trial NCT04538352 · COMPLETED

Trial details

NCT number: NCT04538352
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2021-01-18
Primary completion: 2023-03-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.